Generic Sterile Injectable Market Revenue 2024 to 2034
Generic Sterile Injectable Market Revenue 2024 to 2034
The global generic sterile injectable market was estimated at US$ 42.42 billion in 2023 and is projected to grow to US$ 119.82 billion by 2034, rising at a compound annual growth rate (CAGR) of 9.9% from 2024 to 2034. For people who belong to the poor class or in underdeveloped countries where branded medicines are very expensive, the market for generic medicines grows strongly due to their affordability.
Report ID: 10236
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD USD 46.62 Bn
Forecast Year,
USD USD 82.14 Bn
CAGR, 2025 -
9.9%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Generic Sterile Injectable Market Size Analysis
Generic Sterile Injectable Market Size By Drug Type 2024 to 2034 (USD )
| Drug Type | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Monoclonal Antibodies | 9.20 | 9.98 | 10.96 | 11.91 | 12.99 | 14.27 | 15.51 | 16.95 | 18.63 | 20.31 | 22.25 |
| Insulin | 5.57 | 6.18 | 6.72 | 7.43 | 8.30 | 9.12 | 10.14 | 11.23 | 12.22 | 13.63 | 15.07 |
| Cytokines | 3.79 | 4.16 | 4.53 | 4.94 | 5.39 | 6.01 | 6.62 | 7.28 | 7.99 | 9.00 | 10.04 |
| Peptide Hormones | 3.21 | 3.48 | 3.86 | 4.25 | 4.75 | 5.28 | 5.72 | 6.21 | 6.97 | 7.74 | 8.51 |
| Vaccines | 4.64 | 5.09 | 5.54 | 6.05 | 6.62 | 7.19 | 7.87 | 8.72 | 9.46 | 10.32 | 11.50 |
| Immunoglobulin | 3.76 | 4.10 | 4.52 | 4.96 | 5.56 | 6.02 | 6.51 | 7.16 | 8.03 | 8.77 | 9.53 |
| Blood Factors | 3.32 | 3.71 | 4.08 | 4.51 | 5.00 | 5.50 | 6.07 | 6.66 | 7.29 | 7.95 | 8.58 |
| Antibiotics | 7.11 | 7.87 | 8.71 | 9.65 | 10.42 | 11.46 | 12.79 | 13.99 | 15.28 | 16.75 | 18.45 |
| Others | 6.01 | 6.67 | 7.38 | 8.17 | 8.98 | 9.89 | 10.92 | 12.08 | 13.34 | 14.57 | 15.89 |
Generic Sterile Injectable Market Size By Therapeutic Application 2024 to 2034 (USD )
| Therapeutic Application | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cancer | 14.12 | 15.51 | 17.01 | 18.37 | 20.29 | 22.41 | 24.65 | 27.43 | 30.61 | 33.63 | 37.33 |
| Diabetes | 5.66 | 6.14 | 6.80 | 7.61 | 8.26 | 9.00 | 10.01 | 10.75 | 11.69 | 12.66 | 13.78 |
| Cardiovascular Disease | 4.58 | 5.00 | 5.44 | 6.09 | 6.64 | 7.45 | 8.06 | 8.95 | 9.89 | 10.88 | 12.01 |
| Central Nervous System | 3.73 | 4.11 | 4.45 | 4.97 | 5.39 | 5.94 | 6.53 | 7.25 | 7.90 | 8.72 | 9.62 |
| Infectious Disorders | 7.05 | 7.85 | 8.55 | 9.51 | 10.60 | 11.54 | 12.49 | 13.57 | 14.64 | 16.34 | 17.64 |
| Musculoskeletal System | 4.56 | 4.97 | 5.58 | 6.10 | 6.85 | 7.43 | 8.31 | 9.02 | 10.00 | 11.14 | 12.35 |
| Others | 6.92 | 7.67 | 8.49 | 9.22 | 9.98 | 10.97 | 12.08 | 13.31 | 14.48 | 15.67 | 17.10 |
Generic Sterile Injectable Market Size By Distribution Channel 2024 to 2034 (USD )
| Distribution Channel | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital Pharmacies | 25.45 | 27.98 | 30.61 | 33.30 | 36.83 | 40.68 | 44.68 | 49.52 | 54.26 | 59.45 | 65.42 |
| Online Pharmacies | 7.10 | 7.88 | 8.83 | 9.68 | 10.72 | 11.48 | 12.51 | 13.87 | 15.19 | 16.83 | 18.44 |
| Retail Pharmacies | 9.33 | 10.17 | 11.22 | 12.55 | 13.64 | 15.00 | 16.78 | 18.05 | 19.99 | 21.86 | 23.80 |
| Others | 4.74 | 5.21 | 5.65 | 6.35 | 6.82 | 7.58 | 8.17 | 8.83 | 9.76 | 10.89 | 12.17 |
Generic Sterile Injectable Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 18.51 | 20.26 | 22.41 | 24.38 | 26.79 | 29.31 | 32.02 | 35.13 | 38.72 | 42.02 | 46.62 |
| Asia Pacific | 13.27 | 14.74 | 16.17 | 17.94 | 19.65 | 21.41 | 23.25 | 25.39 | 28.00 | 30.63 | 33.48 |
| Europe | 10.15 | 11.12 | 12.08 | 13.29 | 14.78 | 16.47 | 18.54 | 20.53 | 22.42 | 25.14 | 27.40 |
| Latin America | 2.35 | 2.59 | 2.90 | 3.26 | 3.51 | 3.89 | 4.25 | 4.72 | 5.16 | 5.79 | 6.41 |
| Middle East and Africa | 2.33 | 2.53 | 2.74 | 3.01 | 3.28 | 3.65 | 4.09 | 4.51 | 4.91 | 5.45 | 5.91 |
Generic Sterile Injectable Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
